173 related articles for article (PubMed ID: 19344900)
1. Mesenchymal stem cell-based gene therapy with prostacyclin synthase enhanced neovascularization in hindlimb ischemia.
Ishii M; Numaguchi Y; Okumura K; Kubota R; Ma X; Murakami R; Naruse K; Murohara T
Atherosclerosis; 2009 Sep; 206(1):109-18. PubMed ID: 19344900
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia.
Madonna R; Taylor DA; Geng YJ; De Caterina R; Shelat H; Perin EC; Willerson JT
Circ Res; 2013 Sep; 113(7):902-14. PubMed ID: 23780385
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic mesenchymal stem cells engraft and ameliorate limb ischaemia in allogeneic recipients.
Huang WH; Chen HL; Huang PH; Yew TL; Lin MW; Lin SJ; Hung SC
Cardiovasc Res; 2014 Feb; 101(2):266-76. PubMed ID: 24220639
[TBL] [Abstract][Full Text] [Related]
4. Fucoidan protects mesenchymal stem cells against oxidative stress and enhances vascular regeneration in a murine hindlimb ischemia model.
Han YS; Lee JH; Jung JS; Noh H; Baek MJ; Ryu JM; Yoon YM; Han HJ; Lee SH
Int J Cardiol; 2015 Nov; 198():187-95. PubMed ID: 26163916
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) enhances engraftment and angiogenesis of mesenchymal stem cells in diabetic hindlimb ischemia.
Lu D; Zhang L; Wang H; Zhang Y; Liu J; Xu J; Liang Z; Deng W; Jiang Y; Wu Q; Li S; Ai Z; Zhong Y; Ying Y; Liu H; Gao F; Zhang Z; Chen B
Diabetes; 2012 May; 61(5):1153-9. PubMed ID: 22266669
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Gremlin1 in Mesenchymal Stem Cells Improves Hindlimb Ischemia in Mice by Enhancing Cell Survival.
Xiang Q; Hong D; Liao Y; Cao Y; Liu M; Pang J; Zhou J; Wang G; Yang R; Wang M; Xiang AP
J Cell Physiol; 2017 May; 232(5):996-1007. PubMed ID: 27579673
[TBL] [Abstract][Full Text] [Related]
7. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model.
Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y
Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934
[TBL] [Abstract][Full Text] [Related]
8. Profound Actions of an Agonist of Growth Hormone-Releasing Hormone on Angiogenic Therapy by Mesenchymal Stem Cells.
Ma Q; Xia X; Tao Q; Lu K; Shen J; Xu Q; Hu X; Tang Y; Block NL; Webster KA; Schally AV; Wang J; Yu H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):663-672. PubMed ID: 26868211
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia.
Hoffmann J; Glassford AJ; Doyle TC; Robbins RC; Schrepfer S; Pelletier MP
Thorac Cardiovasc Surg; 2010 Apr; 58(3):136-42. PubMed ID: 20379963
[TBL] [Abstract][Full Text] [Related]
10. Enhanced angiogenesis by transplantation of mesenchymal stem cell sheet created by a novel magnetic tissue engineering method.
Ishii M; Shibata R; Numaguchi Y; Kito T; Suzuki H; Shimizu K; Ito A; Honda H; Murohara T
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2210-5. PubMed ID: 21757660
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice.
Koch JM; D'Souza SS; Schwahn DJ; Dixon I; Hacker TA
Cytotherapy; 2016 Feb; 18(2):219-28. PubMed ID: 26740280
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced therapeutic neovascularization in a mouse model of an ischemic limb using cell aggregates composed of HUVECs and cbMSCs.
Huang CC; Chen DY; Wei HJ; Lin KJ; Wu CT; Lee TY; Hu HY; Hwang SM; Chang Y; Sung HW
Biomaterials; 2013 Dec; 34(37):9441-50. PubMed ID: 24054844
[TBL] [Abstract][Full Text] [Related]
13. Umbilical cord-derived mesenchymal stem cells isolated by a novel explantation technique can differentiate into functional endothelial cells and promote revascularization.
Xu Y; Meng H; Li C; Hao M; Wang Y; Yu Z; Li Q; Han J; Zhai Q; Qiu L
Stem Cells Dev; 2010 Oct; 19(10):1511-22. PubMed ID: 20170363
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
[TBL] [Abstract][Full Text] [Related]
15. Protein profiling and angiogenic effect of hypoxia-cultured human umbilical cord blood-derived mesenchymal stem cells in hindlimb ischemia.
Han KH; Kim AK; Kim MH; Kim DH; Go HN; Kang D; Chang JW; Choi SW; Kang KS; Kim DI
Tissue Cell; 2017 Dec; 49(6):680-690. PubMed ID: 28958480
[TBL] [Abstract][Full Text] [Related]
16. Vascular incorporation of endothelial colony-forming cells is essential for functional recovery of murine ischemic tissue following cell therapy.
Schwarz TM; Leicht SF; Radic T; Rodriguez-Arabaolaza I; Hermann PC; Berger F; Saif J; Böcker W; Ellwart JW; Aicher A; Heeschen C
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):e13-21. PubMed ID: 22199368
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model.
Yao Z; Liu H; Yang M; Bai Y; Zhang B; Wang C; Yan Z; Niu G; Zou Y; Li Y
Stem Cell Res Ther; 2020 Jun; 11(1):221. PubMed ID: 32513272
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of neovascularization in murine hindlimb ischemia by combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells transplantation.
Li Y; Zhang D; Zhang Y; He G; Zhang F
J Biomed Sci; 2010 Sep; 17(1):75. PubMed ID: 20846454
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse.
Bir SC; Esaki J; Marui A; Yamahara K; Tsubota H; Ikeda T; Sakata R
J Vasc Surg; 2009 Oct; 50(4):870-879.e2. PubMed ID: 19679427
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway.
Han JK; Lee HS; Yang HM; Hur J; Jun SI; Kim JY; Cho CH; Koh GY; Peters JM; Park KW; Cho HJ; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
Circulation; 2008 Sep; 118(10):1021-33. PubMed ID: 18711014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
